Advanced search
Publication Cover
mAbs Volume 15, 2023 - Issue 1
Submit an article Journal homepage
8,027
Views
6
CrossRef citations to date
0
Altmetric
Report

Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans

Hans Peter Grimma Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, SwitzerlandView further author information
,
Vanessa Schumachera Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, SwitzerlandView further author information
,
Martin Schäferb Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Munich, GermanyView further author information
,
Sabine Imhof-Jungb Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Munich, GermanyView further author information
,
Per-Ola Freskgårda Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, SwitzerlandView further author information
,
Kevin Bradya Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, SwitzerlandView further author information
,
Carsten Hofmanna Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, SwitzerlandView further author information
,
Petra Rügerb Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Munich, GermanyView further author information
,
Tilman Schlothauerb Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Munich, GermanyView further author information
,
Ulrich Göpfertb Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Munich, GermanyView further author information
,
Maximilian Hartlb Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Munich, GermanyView further author information
,
Sylvia Rottachb Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Munich, GermanyView further author information
,
Adrian Zwickb Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Munich, GermanyView further author information
,
Shanon Segera Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, SwitzerlandView further author information
,
Rachel Neffa Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, SwitzerlandView further author information
,
Jens Niewoehnerb Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Munich, GermanyView further author information
&
Niels Janssena Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, SwitzerlandCorrespondence[email protected]
View further author information
 show all
Article: 2261509 | Received 10 May 2023, Accepted 18 Sep 2023, Published online: 12 Oct 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.